InhibitorSelect NF-κB Signaling Pathway Inhibitor Panel

Toxicity: Multiple Toxicity Values, refer to MSDS (O)

A panel containing 14 potent and selective inhibitors useful for the study of NF-κB signaling pathway. This panel contains the following inhibitors: 10 mg of BAY 11-7082 (Cat. No. 196870); 1 mg of IKK Inhibitor VII (Cat. No. 401486); 5 mg of Interleukin1- Receptor-Associated-Kinase-1/4 Inhibitor (Cat. No. 407601); 10 mg of Histone Acetyltransferase Inhibitor II (Cat. No. 382110); 5 mg of MG-132 (Cat. No. 474790); 500 µg of NEMO-Binding Domain-Binding Peptide, Cell-Permeable (Cat. No. 480025); 500 µg of NF-κB SN50, Cell-Permeable Inhibitor Peptide (Cat. No. 481480); 5 mg of PD 98059 (Cat. No. 513000); 5 mg of PDK1/Akt/Flt Dual Pathway Inhibitor (Cat. No. 521275); 1 mg of Trichostatin A, Streptomyces sp. (Cat. No. 647925); 1 mg of TIRAP Inhibitor Peptide, Cell-Permeable (Cat. No. 613570), 1 mg of Tpl2 Kinase Inhibitor (Cat. No. 616373), 1 mg of (5Z)-7-Oxozeaenol, Curvularia sp. (Cat. No. 499610), and 5 mg of JNK Inhibitor II (Cat. No. 420119). Also provided with 15 ml of anhydrous DMSO.

A panel of 14 highly potent and selective inhibitors useful for the study of NF-κB signaling pathway. This panel contains the following inhibitors as well as 15 ml anhydrous DMSO for reconstitution:

Packaged under inert gas

Following reconstitution, aliquot and freeze (-20°C) each inhibitor. Each inhibitor solution is stable for up to 3 months at -20°C.

Please refer to information provided on the CD for reconstitution information of individual inhibitors.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany